Novacap is a global player in pharmaceutical synthesis and specialty ingredients, with a broad portfolio of products and services and a wide range of technologies. The Group offers its clients custom manufacturing services for pharmaceutical and specialty markets as well as a large portfolio of APIs & pharmaceutical intermediates.
Novacap also boasts leading positions in a variety of markets, including cosmetics and fragrances, electronics, home care, food and feed or environment. Driven by its culture of excellence and by its strong entrepreneurial spirit, Novacap offers its customers the best level of services and high-quality products. Novacap is committed to developing itself in a sustainable and responsible way and to improving continuously through its Corporate Social Responsibility (CSR) program.
The group operates 26 industrial plants and 2 main R&D centers, mainly in Europe, Asia and North America.
Our services :
- Custom research & innovation
- Custom development
- Custom manufacturing
- Specialty Generic
- Essentials API’s & Intermediates
- Advanced specialties
More than 3 200 employees
36 industrial plants, R&D units and commercial offices worldwide
More than 1000 customers in more than 80 countries
Novacap aims to become a leader in chemistry and life sciences with a focus on development: targeting continued growth in the pharmaceutical and cosmetics markets.
A structured strategy was implemented to achieve this ambition :
- Increasing our geographic footprint by continuing to leverage our market positioning through expansion into new geographic markets, particularly in countries with favourable macro-trends in target applications.
- Strengthening our business by improving competitiveness, investing in downstream development and enlarging our product portfolio.
- Boosting innovation.